Prev Arrow Stocks

Elevance Health Inc. ($ELV) Stock Forecast: Down 5.3% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Elevance Health Inc.?

Elevance Health, Inc. (ELV) is a health care company listed on the NYSE with a market capitalization of $90.40 billion. ELV has shown strong performance over the past 15 years, outperforming the market with an average annual return of 14.61%.

Why is Elevance Health Inc. going down?

ELV stock is down 5.3% on May 23, 2025 15:45

  • The bearish movement in ELV's stock today can be attributed to the class action lawsuits filed against the company on behalf of its stockholders for potential violations of federal securities laws. This legal uncertainty has likely caused investor concern and led to a sell-off of ELV shares.
  • The negative impact on health care stocks like ELV could have been further exacerbated by the broader market trend, as indicated by the decline in other health care companies such as UnitedHealth and CVS following CMS's announcement of audits on MA contracts.
  • Investors with substantial losses in ELV are being given the opportunity to lead class action lawsuits, adding to the legal pressures faced by the company and contributing to the downward pressure on its stock price.
  • The upcoming class action deadline for ELV shareholders to contact law firms further highlights the legal challenges surrounding the company, potentially leading to continued volatility in its stock performance.

ELV Price Chart

ELV Technical Analysis

ELV News

Robbins LLP Reminds Elevance Health, Inc. Stockholders of the Class Action Against ELV - Contact Us for Information - Elevance Health ( NYSE:ELV )

SAN DIEGO, May 22, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Elevance Health, Inc. ELV common stock between April 18, 2024 and October 16, 2024.

https://www.benzinga.com/pressreleases/25/05/g45574592/robbins-llp-reminds-elevance-health-inc-stockholders-of-the-class-action-against-elv-contact-us-fo

0 News Article Image Robbins LLP Reminds Elevance Health, Inc. Stockholders of the Class Action Against ELV - Contact Us for Information - Elevance Health  ( NYSE:ELV )

$1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today - Elevance Health ( NYSE:ELV )

Elevance Health ELV has outperformed the market over the past 15 years by 2.91% on an annualized basis producing an average annual return of 14.61%. Currently, Elevance Health has a market capitalization of $90.40 billion.

https://www.benzinga.com/insights/news/25/05/45555502/1000-invested-in-elevance-health-15-years-ago-would-be-worth-this-much-today

1 News Article Image $1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today - Elevance Health  ( NYSE:ELV )

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why - UnitedHealth Group ( NYSE:UNH )

CMS announces it will audit all eligible MA contracts for each payment year in newly initiated audits. UnitedHealth, Elevance and CVS stocks are sliding on the news. Discover the top trade setups and strategies beating the S&P this year -live this Wednesday at 6 PM ET. Reserve your free spot now.

https://www.benzinga.com/government/regulations/25/05/45554854/health-care-stocks-like-unitedhealth-cvs-tank-on-wednesday-heres-why

2 News Article Image Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why - UnitedHealth Group  ( NYSE:UNH )

ELV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - Elevance Health ( NYSE:ELV )

SAN DIEGO, May 19, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit - captioned Miller v. Elevance Health, Inc., No. 25-cv-00923 ( S.D. Ind. ) - seeks to represent purchasers of Elevance Health, Inc.

https://www.benzinga.com/pressreleases/25/05/g45488601/elv-investor-alert-robbins-geller-rudman-dowd-llp-announces-that-elevance-health-inc-investors-wit

3 News Article Image ELV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - Elevance Health  ( NYSE:ELV )

ELV SHAREHOLDERS: Investors with Losses on Elevance Health, Inc. are Notified to Contact BFA Law prior to the July 11 Class Action Deadline

New York, New York-- ( Newsfile Corp. - May 18, 2025 ) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. ( NYSE: ELV ) and certain of the Company's senior executives for potential violations of the federal securities ...

https://markets.businessinsider.com/news/stocks/elv-shareholders-investors-with-losses-on-elevance-health-inc.-are-notified-to-contact-bfa-law-prior-to-the-july-11-class-action-deadline-1034740146

4 News Article Image ELV SHAREHOLDERS: Investors with Losses on Elevance Health, Inc. are Notified to Contact BFA Law prior to the July 11 Class Action Deadline

Elevance Health Inc. Price History

17.09.2024 - ELV Stock was down 15.3%

  • Elevance Health's Q3 earnings disappointed, as profits were below estimates due to issues with medical costs, resulting in a pessimistic market sentiment.
  • While the company had a history of surpassing earnings expectations, the latest quarterly results fell short, leading to a drop in the stock price.
  • Concerns about Elevance Health's less optimistic annual forecast may be influencing the market's reaction, suggesting possible obstacles for the company in the future.
  • Investors who had gained substantial profits over the past decade may be capitalizing on their returns, contributing to today's bearish movement in the stock.

17.09.2024 - ELV Stock was down 12.6%

  • ELV reported third-quarter revenues that beat expectations, driven by higher premium yields and product revenue growth, but the stock still experienced a bearish movement.
  • The profit falling short of expectations and issuing a soft annual outlook may have contributed to investor concerns and selling pressure on the stock.
  • Despite the recent underperformance, ELV has a history of beating earnings estimates, which could indicate potential volatility in the stock price based on future reports.
  • The stock's impressive long-term performance, with a significant increase in value over the past decade, may have attracted profit-taking from investors leading to the bearish movement today.

18.09.2024 - ELV Stock was up 5.7%

  • ELV posted third-quarter revenues of $44.7 billion, surpassing predictions and demonstrating a 5.3% year-over-year growth, driven by increased premium yields in the Health Benefits segment and CarelonRx product revenue expansion.
  • Despite the favorable revenue uptick, ELV's earnings were negatively impacted by reduced Medicaid and Medicare memberships, resulting in an earnings shortfall compared to expectations.
  • The market responded positively to the revenue outperformance but exhibited some caution in light of the earnings miss and subdued annual forecast, leading to fluctuations in the stock's price.
  • Investors are currently pondering whether ELV will exceed estimates in the upcoming earnings release, reflecting sustained intrigue and uncertainty concerning the company's performance.

23.00.2025 - ELV Stock was up 3.2%

  • Elevance Health (ELV) experienced a notable upward trend today attributed to favorable developments and market optimism.
  • Despite a decline in medical membership, the company showed a profitable Q4 and raised its dividend by 5%.
  • Operational revenue saw a substantial increase due to enhanced risk-based functionalities and recent acquisitions.
  • Q4 earnings and revenues surpassed expectations, indicating a promising future for the stock.
  • The stock's upward trajectory could be linked to expectations of robust Q4 earnings, despite potential worries over increased expenses.

15.04.2025 - ELV Stock was down 6.1%

  • The announcement of a class action lawsuit may have spooked investors, leading to a sell-off of ELV shares.
  • Despite historically outperforming the market with an annualized return of 13.94%, concerns surrounding the legal proceedings seem to have overshadowed its long-term performance.
  • Investors might be reacting to the uncertainty and potential financial implications of the lawsuit, causing a significant decline in ELV's stock price today.

23.04.2025 - ELV Stock was down 5.3%

  • The bearish movement in ELV's stock today can be attributed to the class action lawsuits filed against the company on behalf of its stockholders for potential violations of federal securities laws. This legal uncertainty has likely caused investor concern and led to a sell-off of ELV shares.
  • The negative impact on health care stocks like ELV could have been further exacerbated by the broader market trend, as indicated by the decline in other health care companies such as UnitedHealth and CVS following CMS's announcement of audits on MA contracts.
  • Investors with substantial losses in ELV are being given the opportunity to lead class action lawsuits, adding to the legal pressures faced by the company and contributing to the downward pressure on its stock price.
  • The upcoming class action deadline for ELV shareholders to contact law firms further highlights the legal challenges surrounding the company, potentially leading to continued volatility in its stock performance.

16.04.2025 - ELV Stock was up 7.7%

  • Despite bearish options activity, the stock of Elevance Health (ELV) experienced a bullish movement today.
  • The announcement of a class action lawsuit may have initially caused some uncertainty among investors, but it seems that the market sentiment quickly turned positive.
  • The long-term outperformance of Elevance Health likely contributed to investor confidence and drove the bullish movement in the stock today.
  • Overall, the positive market movement of ELV could be attributed to the company's strong historical performance and resilience in the face of legal challenges.

03.03.2025 - ELV Stock was up 5.1%

  • ELV stock exhibited significant upward movement today, potentially influenced by its consistent market outperformance over the past 15 years.
  • Investor sentiment towards the company's future prospects may be positive, leading to heightened buying interest and an uptick in the stock price.
  • The remarkable growth trajectory of Elevance Health and its consistent delivery of above-average returns could have captured the attention of more investors, contributing to the bullish momentum witnessed in the stock today.

22.04.2025 - ELV Stock was down 5.4%

  • ELV stock plummeted due to the announcement of a class action lawsuit indicating potential violations by the company and its executives, leading to investor uncertainty and selling pressure.
  • The broader health care sector, including companies like UnitedHealth and CVS, also faced a downturn following regulatory actions, adding to the negative sentiment in the industry.
  • Investors with substantial losses in ELV are being urged to participate in the class action lawsuit, further exacerbating the negative outlook for the company and contributing to the bearish market movement.
  • The legal challenges and uncertainties surrounding Elevance Health have overshadowed its historical market outperformance, causing a sharp decline in its stock price today.

12.01.2025 - ELV Stock was down 2.1%

  • Despite its historical outperformance, ELV recently saw a notable bearish movement in its stock price.
  • The decline in ELV's stock price may be attributed to profit-taking by investors following a prolonged growth period.
  • Market sentiment may have changed due to factors such as macroeconomic conditions or specific company events.
  • Investors could be reassessing their positions in ELV, leading to the observed bearish movement.

08.03.2025 - ELV Stock was up 5.2%

  • The strong bullish movement in ELV's stock could be attributed to the surge in trading volume observed in the last session, indicating increased investor interest.
  • Despite a notable increase, further upside may be limited in the near term due to trends in earnings estimate revisions.
  • Positive reactions from investors to recent developments or news related to Elevance Health may have contributed to the stock price increase despite potential limitations on future price increases.
  • Monitoring new information or updates regarding ELV is crucial for making informed decisions about investment strategies.

17.03.2025 - ELV Stock was down 6.6%

  • The bearish movement in ELV stock today could be attributed to investors' concerns about the implied volatility surging in the stock options market.
  • The anticipation of the upcoming earnings report might have led to profit-taking by some traders, causing a downward pressure on the stock price.
  • The increased attention on ELV stock options could indicate a higher level of uncertainty or speculative trading, contributing to the bearish trend in the market today.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.